Sun Pharma started operations with five psychiatry products and a two-person marketing team in 1983. Over the next three and half decades, Sun Pharma metamorphosed as the 5th largest Global Speciality Generic Pharmaceutical Company. Today Sun Pharma has commercial presence in more than 100 countries across the world. Sun Pharma manufactures its portfolio of more than 2,000 products in 44 manufacturing sites across India, North America, Asia, Africa, Australia and Europe. Sun pharma employs more than 32,000 employees globally, including 2,000 scientists in its R & D organisation. Cumulative investments in R&D stands at ~$2,3 billion and the organisation has filed and obtained 950 patents. Approximately 35% of the organisation revenues are from its USA operations and another one third from its Indian operations. Emerging Markets business contributes ~18% of the business turnover. Sun Pharma defines its core purpose in its vision statement are reaching people and touching lives'. Sun Pharma is operational in Myanmar for more than 25 years and is amongst the leading pharmaceutical organisations in Myanmar.